BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8340058)

  • 1. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Scheynius A; Hultcrantz R
    Hepatology; 1993 Aug; 18(2):298-303. PubMed ID: 8340058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Hultcrantz R; Scheynius A
    Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
    Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.
    Cruickshank SM; Southgate J; Wyatt JI; Selby PJ; Trejdosiewicz LK
    J Clin Pathol; 1999 Oct; 52(10):730-4. PubMed ID: 10674028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.
    Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J
    Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis.
    Ballardini G; Mirakian R; Bianchi FB; Pisi E; Doniach D; Bottazzo GF
    Lancet; 1984 Nov; 2(8410):1009-13. PubMed ID: 6208447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Sasatomi K; Noguchi K; Sakisaka S; Sata M; Tanikawa K
    J Hepatol; 1998 Sep; 29(3):409-16. PubMed ID: 9764987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.
    Chapman RW; Kelly PM; Heryet A; Jewell DP; Fleming KA
    Gut; 1988 Apr; 29(4):422-7. PubMed ID: 3286382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis.
    Spengler U; Leifeld L; Braunschweiger I; Dumoulin FL; Lechmann M; Sauerbruch T
    J Hepatol; 1997 Jan; 26(1):31-6. PubMed ID: 9148019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
    Sasaki M; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis.
    Broomé U; Grunewald J; Scheynius A; Olerup O; Hultcrantz R
    J Hepatol; 1997 Mar; 26(3):527-34. PubMed ID: 9075659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
    Bloom S; Fleming K; Chapman R
    Gut; 1995 Apr; 36(4):604-9. PubMed ID: 7537707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography.
    Ben-Ari Z; Panagou M; Patch D; Bates S; Osman E; Pasi J; Burroughs A
    J Hepatol; 1997 Mar; 26(3):554-9. PubMed ID: 9075662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases.
    Martins EB; Chapman RW; Marron K; Fleming KA
    J Clin Pathol; 1996 Jan; 49(1):53-6. PubMed ID: 8666687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis.
    Sakisaka S; Koga H; Sasatomi K; Ohishi M; Kawaguchi T; Harada M; Taniguchi E; Uchimura Y; Ueno T; Sata M; Tanikawa K
    Liver; 2000 Feb; 20(1):78-87. PubMed ID: 10726964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
    Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
    Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
    Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.
    Takahashi T; Miura T; Nakamura J; Yamada S; Miura T; Yanagi M; Matsuda Y; Usuda H; Emura I; Tsuneyama K; He XS; Gershwin ME
    Hepatology; 2012 Mar; 55(3):846-55. PubMed ID: 22031474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.